Navigation Links
Therapure Awarded $4.2 Million BIP Grant from the Ontario Government
Date:4/29/2010

Therapure Biopharma Inc. today announced that it has been awarded a $4.2 million grant from the Ontario Ministry of Research and Innovation’s Biopharmaceutical Investment Program (BIP). Therapure will utilize the funding to support a $27.9 million expansion of its bio-manufacturing facility in Mississauga, Ontario, Canada.

Toronto, ON (Vocus) April 30, 2010 -- Therapure Biopharma Inc. today announced that it has been awarded a $4.2 million grant from the Ontario Ministry of Research and Innovation’s Biopharmaceutical Investment Program (BIP). Therapure will utilize the funding to support a $27.9 million expansion of its bio-manufacturing facility in Mississauga, Ontario, Canada.

"We are thrilled that the government of Ontario has recognized the strength and potential of Therapure’s resources and talented people with this investment, which will help position our company and Ontario to be an international leader in bio-manufacturing and biosimilars," said Thomas Wellner, President and CEO of Therapure. "The support that we are receiving from the Ontario government will help enhance our state-of-the-art facility in Mississauga and improve Therapure’s ability to partner with the biopharmaceutical sector to bring new protein-based therapies to the patient."

"Ontario is investing strategically to help innovative companies to compete in emerging markets where Ontario can be a global leader," said John Milloy, Minister of Research and Innovation. "Today’s investment builds Ontario’s research strength and creates jobs and a healthier future for our families."

"Mississauga is proud to be home to a world-class biopharmaceutical company such as Therapure, and I would like to congratulate Tom Wellner and his colleagues at Therapure on receiving this grant," added Mayor Hazel McCallion of Mississauga. “Having visited their facility, I was pleased to support Therapure’s BIP application, and I look forward to the company’s continued growth. Therapure brings high value added employment to our community, and is gaining a well-deserved reputation as a centre for biopharmaceutical research, development and manufacturing."

About Therapure Biopharma Inc.:
Therapure Biopharma Inc. is an integrated biopharmaceutical company that develops, manufactures, purifies and packages therapeutic proteins and biosimilars. As a contract development and manufacturing organization (CDMO), Therapure Biopharma applies scientific, manufacturing, and downstream purification expertise with an intimate understanding of advanced biology, complex proteins, and regulatory processes to develop effective and innovative solutions to advance products from discovery to market for its clients. Therapure’s Health Canada-licensed 130,000 sq. ft. facility includes manufacturing, research and quality-control laboratories and a cGMP warehouse, and is built to U.S. FDA, EMEA, MHRA and Health Canada standards for the aseptic handling and purification of proteins.

For more information, please visit: www.therapurebio.com

Company Contact:
Thomas Wellner, President and CEO
Therapure Biopharma Inc.
+1 905 286-6204
ceo(at)therapurebio(dot)com

###

Read the full story at http://www.prweb.com/releases/2010/04/prweb3943064.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Therapure Biopharma Inc. signs fill/finish contract with Kane Biotech Inc.
2. Therapure Biopharma Inc. signs multi-year manufacturing agreement with LFB Biomedicaments
3. Therapure Biopharma Inc. Commissions its Commercial-Scale Lyophilizer
4. Microbix and Therapure Biopharma Form Partnership to Expand Water-Based Supplies to the Pharma Industry
5. Therapure Biopharma Inc. and YM BioSciences Inc. Announce Partnership
6. Therapure Biopharma Inc. and Akorn, Inc. Announce Strategic Supply Contract
7. LA BioMed awarded research grant to study HIV prevention gel
8. £3M awarded for climate model to predict disease outbreak
9. Onyx M.D. Awarded GSA Schedule Contract Creating Increases Access to Government Physician Jobs
10. OHSU awarded $5.8 million to expand health information technology education
11. SWOG cancer trials network awarded over $120 million in NCI grants
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Therapure Awarded $4.2 Million BIP Grant from the Ontario Government
(Date:6/24/2016)... ... 24, 2016 , ... Finally, a bruise cream that really works. Originally ... incorporated into the post-surgical treatment plans of a variety of other procedures including, but ... very effective for bruising and causes a rapid resolution of bruising and inflammatory changes ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Markarian, DDS, are co-chairs for the Illinois State Dental Society (ISDS) Foundation’s Mission ... at the Gateway Convention Center in Collinsville. , They expect to ...
(Date:6/24/2016)... ... 24, 2016 , ... SpiritQuest Sedona Retreats, located in Arizona has re-located to ... vortex sites: Cathedral Rock, Airport Mesa, and Boynton Canyon. The new retreat center ... as well as the Sedona Rouge, both popular accommodations for SpiritQuest clients. The ...
(Date:6/23/2016)... Colo., USA (PRWEB) , ... June 23, 2016 ... ... and Sanquin Blood Supply Foundation, a not-for-profit organization responsible for clinical transfusion research ... of patient enrollment for the Pathogen Reduction Evaluation and Predictive Analytical Rating Score ...
(Date:6/23/2016)... ... June 23, 2016 , ... vcfo, a consulting firm that ... to announce the promotion of Mike Mackey to Regional Vice President of Southeast ... was responsible for managing client projects and overseeing vcfo financial consultants in the ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
(Date:6/23/2016)... 2016 Revolutionary technology includes multi-speaker ... , industry leaders in advanced audiology and hearing aid ... Opn ™, the world,s first internet connected hearing aid ... devices.      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ) ... of ,world firsts,: , TwinLink™ - the ...
Breaking Medicine Technology: